Quantitative and qualitative aspects of the in vivo micronucleus-inducing potential of five chemicals were studied using flow cytometric enumeration of micronucleated polychromatic peripheral blood erythrocytes in mice. The chemicals were hydroquinone, vinblastine sulphate, chloral hydrate (tested in two different mouse strains), 5-bromo-2-deoxyuridine and 2-chlorobenzylidene malonitrile. 
Introduction
Automated methods for the detection of genetic damage have been proposed for the detection of relevant cells and quantification of damage. However, the potential of automated techniques is not limited to replacing the human observer at the microscope, but can ideally be used to enhance existing assays, e.g. by increasing sensitivity through the analysis of large cell numbers and by providing additional information. Examples of the latter are quantitative fluorescence data related to: (i) differential antibody binding to erythrocytes showing NO or NN phenotypes in the glycophorin A assay (Jensen et al, 1995) ; (ii) the size or DNA content of micronuclei (MN) (NUsse et al, 1992a,b) ; and (iii) the sorting of denned subpopulations of MN or MN-containing cells for subsequent analysis (Graw6 et al, 1994) .
The in vivo micronucleus test in bone marrow (Heddle, 1973) or peripheral blood erythrocytes (MacGregor et al, 1980) is widely used as a short-term assay for the detection of agents able to induce chromosome aberrations in somatic cells (Mavournin et al., 1990; Heddle et al., 1991; Hayashi et al., 1994a) , and has also been shown to have good predictive potential for the identification of germ cell mutagens (Waters et al., 1994) . We have earlier shown that the use of flowcytometric quantification of micronucleated polychromatic and normochromatic erythrocytes (MPCE and MNCE) provides additional advantages beyond replacing manual enumeration. Because of the high number of polychromatic erythrocytes (PCE) screened may easily be increased by a factor of 100. Using ionizing radiation as inducer of MN, the flow-cytometric assay showed a sensitivity increase of ~ 10-fold in comparison with manual counting (Graw6 et al., 1993b; Zetterberg and Graw6, 1993; Abramsson-Zetterberg et al., 1995) . It is even possible to study in detail the kinetics of in vivo MN induction after low exposures to ionising radiation (Abramsson- Zetterberg et al., 1996) .
The micronucleus assay in bone marrow erythrocytes has been proposed as an assay with the potential to specifically detect the action of aneugens. Several approaches to detect intact chromosomes have been used. The diameter or fluorescence intensity of MN, which are related to the DNA content of the MN, have been measured (Yamamoto and Kikuchi, 1980; Graw6 et al, 1993a) . Alternatively, the presence of centromeric regions may be studied by kinetochore-specific antibodies or fluorescent in situ hybridization (FISH) using DNA probes specific for centromeric sequences (Miller and Adler, 1990; Miller, et al, 1991; Schriever-Schwemmer and Adler, 1994; Graw6 et al, 1994) .
The techniques to specifically detect erythrocytes with MN containing intact chromosomes have almost exclusively been applied to the bone marrow. With the increasing use of peripheral blood erythrocytes for MN enumeration in the in vivo micronucleus test, it is of interest to ascertain whether these MN also retain characteristics reflecting the mechanism (clastogenic or aneugenic) by which they were induced. An obstacle to directly applying the methods developed for bone marrow erythrocytes is the low frequency (~2%) of relevant cells (PCE) in the peripheral blood. Therefore, it is difficult to find enough peripheral blood MPCE for a statistically reliable determination of the proportion of centromere-or kinetochore-containing PCE. Hayashi et al (1994b) have reported on the use of a centromere-specific probe to detect centromeres in MN isolated from mouse peripheral blood erythrocytes after treatments with model clastogens and aneugens. As these authors note, such studies should ideally be made on MN in immature erythrocytes, which are the target population.
Studies of the relative DNA content distribution of induced MN is best performed on large populations of MN. With flow-cytometric enumeration such information can readily be obtained, even when the analysis is restricted to MN in peripheral blood PCEs.
Flow-cytometric analysis of induced MPCE populations after treatment with model aneugens and clastogens revealed differences in the mean relative DNA content and the shape of the DNA content distributions apparent in the flow cytometric dot plots and histograms from both bone marrow and peripheral blood erythrocytes, reflecting the respective mechanisms of action (Graw6 et al. 1993a) . Information on the mean relative DNA content of MN as well as visual inspection of dot plots and histograms should aid in interpreting experimental results.
The present report shows the potential of the flow cytometric analysis of micronucleated peripheral blood PCE to increase the amount of experimental data available as a basis for quantitative and qualitative evaluation of the chromosomedamaging potential of a selection of chemicals. Five agents were tested, substantially increasing the number of agents studied with the flow cytometric methodology used herein. Vinblastine (VBL), hydroquinone (HQ) and chloral hydrate (CH) have been included in a CEC (Commission of the European Communities)-commissioned evaluation of tests for the detection of aneuploidy (Adler, 1993) . 2-Chlorobenzylidene malonitrile (CS) is used as a tear gas. It has been shown to be an in vitro aneugen (NUsse et al, 1992b; Miller and Nusse, 1993) and to induce c-mitotic effects in vitro (Salassidis et al, 1991) . 5-Bromo-2-deoxyuridine (BrdU) is a base analogue which can be incorporated into DNA in place of thymidine. It is reported to be clastogenic in vitro in CHO cells but not in 3T3 cells (Weller et al., 1993) . In vivo data on MN induction is limited to a single study by Bruce and Heddle (Bruce and Heddle, 1979) . BrdU is administered to patients with tumours for in situ determinations of cell cycle parameters (Nemoto et al., 1990; Sasaki et al., 1992; Cooke et al., 1994) . BrdU may also be administered to animals treated with suspected genotoxins in order to obtain differential staining of chromatids in metaphases from bone marrow cells harvested after treatment. If the bone marrow of these animals is also used for assessment of MN induction, there is a possibility that BrdUinduced MN may interfere with the interpretation of data. Presently, MN induction and mean relative DNA content of MN in mouse peripheral blood were quantified at four to five sampling occasions after exposure. Repeat samplings from the same individuals reduced animal usage.
In a second paper, we report the result of experiments intended to explore the composition of MN induced by different agents by flow sorting of subpopulations of micronucleated bone marrow erythrocytes based on their relative DNA content followed by dual colour FISH with two different centromeric probes (Grawe et al, 1996) .
Materials and methods

Animals
Adult male (102/E1 XC3H/E1)F1 mice bred in the animal colony of the GSFForschungszentrum fllr Umwelt und Gesundheit weighing -28 g and aged 10-12 weeks were used. For the study on chloral hydrate, Balb/c mice of the same weight were used in addition. The animals were given commercial food pellets and tap water ad libitium. Each treatment group consisted of three animals. The experiments have been approved by the Ethical Committee for Animal Experiments of the State of Bavaria (permit no. 211-2531-37/93). Hydroquinone (HQ; , vinblastine sulphate (VBL; CAS no. 143-67-9), chloral hydrate (CH; CAS no. 302-17-0) and were provided by J.M.Parry (original source Sigma), Swansea, UK. 5-Bromo-2-deoxyuridine (BrdU; CAS DO. 59-14-3) was purchased from Sigma (MUnchen, Germany). 2-Chlorobenzylidene malonitnle (CS; CAS no. 2698-41-1) was the kind gift of Dr U.Andreae (GSF-Institut fllr Toxikologie, original supplier Klever, Aham, Germany). HQ, VBL and CH were dissolved in bidistilled water; CS and BrdU in 100% dimethylsulphoxide (DMSO).
Chemicals
Treatment, blood sampling and purification All substances were given as a single treatment by i.p. injection. Injected volumes were 10 |il/g body weight for agents dissolved in bidistilled water and 5 ul/g body weight for agents dissolved in DMSO. The doses given were 0.05, 0.1, 0.25 and 0.5 mg/kg for VBL; 12.5, 25, 50 and 75 mg/kg for HQ; 200, 400, 800 and 1600 mg/kg for BrdU; 10, 20 and 40 mg/kg for CS, and 200 mg/kg for CH. Blood was sampled from the same animals at 0, 24, 40, 48, 72, and for BrdU, 96 h after injection. Blood sampling was performed by retro-orbital bleeding of animals lightly anaesthesized with anaestheticgrade ether into heparinized tubes; -100 nl per animal per sampling time was collected.
Triplicate samples of 5 |il blood from each animal were layered each onto 1 ml of a Percoll (Pharmacia, Sweden) solution [65% in phosphate-buffered saline (PBS)]. The Percoll tubes were then centrifuged for 20 min at 600 g. The supematants including platelets and the majority of nucleated cells were carefully aspirated. The cell pellet was then fixed as described below.
Erythrocyle fixation and staining
The cells were fixed using a modification of the fixative described by Hayashi et al. (1992b) . As described in Abramsson- Zetterberg et al. (1996) , the erythrocyte pellet was suspended and mixed with 50 |il of PBS. This suspension was sucked up in a pipette and quickly expelled into a tube containing 1 25 ml of a 1 % solution of glutaraldehyde (70% double-distilled, Sigma) in PBS with 30 (ig/ml of sodium dodecyl sulphate (SDS; Sigma) during vigorous vortex mixing. Samples were stored overnight at 4°C. Staining and flow cytometry were conducted within 4 days. Staining buffer was prepared by adding 0.5 ml Hoechst 33342 stock (HO342, Sigma, 250 ug/ml in distilled water) and 50 ul Thiazole Orange stock (TO; 1 mg/ml in methanol. Molecular Probes, Eugene, OR, USA) to 100 ml PBS. The fixed samples were allowed to settle overnight The supernatant was aspirated and 1 ml of staining buffer added, upon which the samples were gently mixed. The staining continued for 45 min in the dark at 37°C. Samples were mixed every 10 min by inverting the tubes.
Flow cytometric analysis
The samples were analysed on a FACStar Plus flow cytometer (Becton Dickinson, Sunnyvale, CA, USA) equipped with an argon ion laser (Coherent Innova 90, Coherent, CA, USA) operating at the 488 nm line, 1 W as primary laser and a second argon ion laser operating at the 351-364 nm multiple UV lines at 200 mW (Coherent Innova 90; Coherent). The analysis rate was 1000 erythrocytes/s with a threshold in forward scatter (FSC) set to include all intact cells. Peak values for FSC, side scatter (SSC), TO fluorescence and HO342 fluorescence signals were collected in list mode on a Hewlett-Packard computer (Hewlett-Packard, Fort Collins, CO, USA) running LYSYS II software. Standard FACStar Plus filter sets were used. The FSC signals were acquired using a linear scale, while the SSC, TO, and HO342 signals were acquired using a 4-decade log scale. A live gate was used in the FSC and SSC parameters to exclude residual nucleated cells (NC) and debris, thereby restricting data acquisition to an almost pure population of erythrocytes (Grawe«a/., 1992 (Grawe«a/., , 1993a .
For analysis of PCE, only a threshold level was established for TO fluorescence which excluded virtually all normochromatic erythrocytes (NCE) (Grawe' et al. 1992 (Grawe' et al. , 1993a . Use of the TO fluorescence threshold increased the analysis rate to 500-1000 PCE/s. Each sample was analysed twice. In the first analysis 10 000 events were acquired using the FSC threshold set to include all intact erythrocytes. Data from this file were later used for the determination of the percentage of PCE. In the second analysis using the TO threshold for analysis of PCE only, 50 000 events were collected from each sample, -45 000 of which were PCE. This file was used for the determination of MPCE frequencies. Figure 1 illustrates the appearance of the flow cytometric data and also shows how regions of interest for the NCE, PCE and MPCE populations were determined. These regions were drawn to fit the shapes of the respective populations as well if possible and to exclude MNCE. Results from sorting experiments have shown that the events enclosed by gates set in this way contain >90?J: true MPCE in samples from treated animals (Grawi et al., 1992 (Grawi et al., , 1993a . These regions, once determined, were kept constant for all the files analysed. 
Calculation of PCE, MPCE and MNCE frequencies
For each sample dot plots representing DNA content versus RNA content were displayed using the DAS data analysis program (Beisker, 1994) . Regions of interest were defined for NCE and PCE using files containing data from the entire erythrocyte population (Figure la) and MPCE using files thai were acquired using a TO fluorescence threshold to eliminate normochromatic erythrocytes (Figure lb-e) . The absolute number of events in the regions of interest for NCE, PCE and MPCE respectively (nNCE, nPCE, nMPCE) were summed for the triplicate samples. In some cases fewer than three parallel samples were analysed. The respective frequencies of MPCE and PCE were then calculated. The fMPCE was plotted as a function of the time and concentration of the chemicals. In order to minimize the effect of dose-related differential cell cycle delays the area the induction of MPCE was integrated over time and the area below the curve (ABC) was plotted as a function of the concentration of the chemicals (Morales- Ram'rez et al, 1994) . For these calculations, the fMPCE found at time 0 for each animal was subtracted from the fMPCE found for the same animal at each subsequent sampling time. The time span used differed between the agents, because severe depressions in the PCE frequencies at higher treatment levels of VBL and BrdU limited the useable time span to 48 and 72 h respectively. The values for the ABC were presented as (MPCEXhyiOOO PCE
HO342 fluorescence as a measure of the relative DNA content of MN
HO342 is known to bind quantitatively to DNA. However, DNA binding is also affected by the structure of the chromatin. Since the chromatin in late erythroblasts and in MN is known to be highly packed and heterochromatic, the binding of HO342 per unit DNA in MN may be less than the binding to DNA in nucleated bone marrow cells. The mean HO342 fluorescence of the MPCE population from different animals subjected to the same treatment was, however, very similar, and the differences in the HO342 fluorescence in the MPCE populations between treatments was highly reproducible. Therefore, we use the mean HO342 fluorescence of the populations of MPCE shown in Figure 1 as an index of the mean relative DNA content. The mean HO342 fluorescence was expressed as the mean channel number for the fluorescence intensity determined by the analysis program. In this way the populations of MN were compared with each other, and not with the nucleated bone marrow cells.
Statistical analysis
For all comparisons between groups, a one-tailed Student's (-test was used. Significance values were divided by the number of comparisons made for each treatment group in order to compensate for multiple comparisons.
Results
Control frequencies
Of the 17 treatment groups used, 16 were of the same strain, (1O2/E1XC3H/E1)F1. In these groups there was an evident variation between groups in control frequencies (at sampling time 0), with mean group MPCE control frequencies (n = 3) between 0.0015 and 0.0024. Such differences have also been observed using manual assessment (Mitchell et al, 1988) . Differences of this magnitude will hardly be significant when 2000 PCE per animal are counted, but since the number of PCE analysed and MPCE found here was much higher, the sampling error was reduced and these differences become significant. Components of this variation were inter-individual variation, but also differences in staining and analysis conditions, as these analyses were conducted over a time period of 6 months. Under these circumstances the pooling of control groups will reduce the sensitivity of the assay with respect to the detection of small elevations of the MPCE frequency. Therefore, all treatment groups were compared within themselves between 0 h and later sampling times, providing internal controls (Tomatsko et al., 1995) . Table I gives the control frequencies for all animals analysed.
Vinblastine
In Table I the results of the VBL experiment are tabulated. The lowest dose at which an elevated fMPCE was registered was 0.05 mg/kg at 48 h after exposure. Figure 2a shows the time dependence of MPCE induction in the peripheral blood at four different dose levels. For the 0.1 and 0.25 mg/kg dose levels, the maximal response was found at 40 h after exposure, while at 0.5 mg/kg it was at 48 h after exposure. At 24 h the response was only beginning to rise, and at 72 h the bone marrow toxicity for the 0.5 mg/ kg dose precluded measurements of the MPCE level. The dot plot in Figure lc shows a tightly clustered MPCE population with only a small number of MN with low HO342 fluorescence, which is characteristic for an aneugen as shown earlier for vincristine and colchicine (Cao et al, 1993; Grawe et al, 1993a) . The HO342 fluorescence index was substantially elevated for the 0.5 mg/kg dose (Figure 3 ), peaking at 40 h. For VBL the best dose-response fit was linear-quadratic up to 0.25 mg/kg (Figure 2d ). For the 0.5 mg/kg dose, the ABC is probably underestimated, as can be seen from Figure la where the MPCE response to this dose has not started to decrease at 48 h. The PCE depression (Table I) , however precluded measurements at 72 h.
Hydroquinone
The flow cytometry dot plot showed a bimodal pattern in the HO342 fluorescence of the MPCE population ( Figure Id) . The HO342 fluorescence index increased above the control value with a peak at the 24 h sampling time ( Figure 3 ).
As Table I shows, a small but significant increase in the fMPCE was seen already for 25 mg/kg at 24 and 40 h after treatment but not at 48 h. For this agent, the maximal response at all dose levels was at 40 h after treatment (Figure 2b ). For the dose levels 25 and 50 mg/kg the 24 h sampling time showed a MN induction close to the level at 40 h. The shape of the dose-response curve was biphasic and for the entire concentration range the best fit was linear-quadratic ( Figure  2e ). However, for the doses of 25-75 mg/kg there is a very good linear fit. Taken together with the fact that at the 12.5 mg/kg dose there is no significant elevation of the fMPCE, this suggests that there might exist a no-effect threshold in the dose region between 12.5 and 25 mg/kg.
5-Bromo-2-deoxyuridine
The dot plot in Figure le shows a MPCE population with similar characteristics to those of the clastogens cyclophosphamide, X-irradiation (Grawe" et al, 1993a ) and mitomycin C (Cao et al, 1993) . As seen in Figure 3 , the population of induced MPCE shows a HO342 fluorescence index close the control value at 0 h. An increase in the frequency of induced MPCE was seen at the lowest dose tested, 200 mg/kg. At the highest dose levels, the maximum response was delayed to 72 h after treatment, while at the two lower levels 48 and 72 h samplings showed about the same level of induced MPCE (Table I, Figure 2c ). At 1600 mg/kg, bone marrow toxicity made the fMPCE determinations unreliable. For BrdU, the shape of the dose-response curves were similar to VBL, with a linearquadratic best fit if the highest dose was excluded (Figure 2f ). For the two highest doses, no measurements of the MPCE frequency were possible at 96 h after treatment due to bone marrow toxicity.
Chloral hydrate This agent was tested at one dose only. The dose chosen has elsewhere been reported to induce MPCE in Balb/c mice (Russo et ai, 1992) . Two strains were tested: Balb/c and (1O2/E1XC3H/E1)F1 hybrids.
All treated animals were clearly sedated after treatment. The difference in baseline levels of MPCE between the two strains are evident (Table I) . At 40 h after treatment, a tendency towards elevated MPCE frequencies was seen for both strains, but in neither case was it significant.
2-Chlorobenzylidene malonitrile
The dose levels chosen were based on an LD 50 of -60 mg/kg (Frankenberg and Sorbo, 1973) . At the doses of 20 and 40 mg/kg, animals became moribund. At the higher dose the signs of toxicity became more severe and one animal died 20 h after treatment. At no dose level or sampling time were there any signs of elevated MPCE frequencies or depressions of the PCE:NCE ratio (Table I) .
Discussion
Of the five agents tested in this study, three (VBL, HQ and BrdU) were positive for MN induction and two (CS and CH) were found to be negative.
The distribution of MN in PCEs in each treatment group may be assumed to closely approximate a Poisson distribution (Mitchell et ai, 1988) . If the spontaneous frequency of MPCE is two per thousand, counting 130 000 cells per animal instead of 2000 reduces the sampling error by a factor of about eight. Since at the control level of fMPCE the sampling variation is the dominating part of total variation observed, an increase in the fMPCE of ~20% over background should be detectable, and a doubling of the control frequency should be highly significant. The smallest significant increases over control frequencies observed in this study were 31% (25 mg/kg, 24 and 40 h sampling times) for HQ and 19% for VBL (0.05 mg/ kg, 48 h). Salamone et al. (1980) have reported that a twotreatment protocol may increase sensitivity without the need for multiple sampling times which make the evaluation burdensome if microscopic analysis is used. On the other hand they noted that with multiple treatments the first treatment may give rise to cell cycle effects which may affect the second treatment, especially at higher doses. This may in turn give misleading dose-response relationships. In our case, the use of more sampling times only requires a relatively minor increase in effort. Therefore, we have chosen to use one treatment time and multiple sampling times. We also used the ABC method for dose-response determinations. However, it should be noted that for the detection of small elevations of the frequency of MPCE which may occur at one or two of the sampling times used, the ABC method is less sensitive than studying each sampling time. The reason for this is that possibly significant elevations of MPCE at a few time points are 'diluted' with non-significant elevations at the other time points with the ABC method. We compared treatments for significant elevations of MPCE frequencies at each sampling time separately.
VBL induces MN in a dose-dependent manner. The distribution of the MPCE population in the flow cytometry dot plot shows the same characteristics as other aneugens tested with the same technique (Graw6 et al, 1993a; Cao et al, 1993) . The majority of MPCE in the designated region are tightly clustered with relatively high HO342 fluorescence. This is consistent with the increase in mean HO342 fluorescence of induced MPCE, and reflects the aneugenic action of this agent.
For HQ the best sampling time after treatment for determination of MPCE in peripheral blood is at 40 h. The commonly used sampling times of 24 and 48 h give substantially lower levels of MPCE. The shape of the ABC dose-response curve is bi-phasic. A study of only the higher doses indicates a possible linear relationship with a no-effect threshold.
The distribution of HO342 fluorescence intensity among induced MPCE, as depicted in Figure Id , is informative. The MPCE population in the HQ dot plot appears to be bimodally distributed. This can be interpreted as a combination of the MPCE populations characteristic of model aneugens and clastogens (Grawe et al, 1993a (Grawe et al, , 1994 and indicates a dual mode of MN-inducing action of HQ. The same pattern was found in bone marrow PCE (Graw6 et al, 1996) . This is the pattern to be expected given the two proposed mechanisms of action of this agent (Miller et al, 1991; Chen et al, 1994) . The mean HO342 fluorescence of induced MN is increased above the control value, but is not as high as the values for VBL.
BrdU induces MPCE at all doses studied. For this agent the peak response occurres later than for VBL or HQ. Similar to VBL, the ABC curve shows a dose-dependent increase in MPCE with the value for 1600 mg/kg probably underestimated due to cell cycle inhibition. The relatively late appearance of BrdU-induced MN may be related to (i) the cell cycle inhibiting action of BrdU (Weller et al, 1993) evident in this study as a depression in the peripheral blood PCE frequency (Table I) , and/or (ii) the fact that this agent when incorporated into nascent DNA may remain there for several cell generations. BrdU incorporated in earlier cell cycles of the erythroblast may therefore induce chromosome breaks in successive cell cycles. A similar delayed action of other nucloside analogues in the peripheral blood micronucleus test has been 'reported earlier (CSGMT, 1992) .
CH has earlier been found to be negative for in vivo MN induction in the bone marrow of (1O2/E1XC3H/E1)F1 mice , and positive in Balb/c mice (Russo et al, 1992) . Both these strains were now compared in the same experiment at the dose level reported to give MN in Balb/c mice. No significant increase in MPCE was found in either strain at any sampling occasion. CH has been found to induce c-mitotic effects in mouse bone marrow cells. Therefore, the possibility remains that this agent causes aneuploidy in vivo by interfering with the centromere so that chromatid separation at anaphase does not occur, leading not to lagging chromosomes but to unequal distribution of chromosomes to the daughter cells (Miller and Adler, 1990) . Such events would not be seen as micronuclei. The difference in baseline MPCE frequencies between (1O2/E1XC3H/E1)F1 and Balb/c mice is evident (Table I) and of the same magnitude as those reported by Salamone and Mavoumin (1994) .
For CS, the data indicate no elevations of MPCE frequencies at any dose or sampling time. CS has been shown to be an in vitro aneugen (Nusse et al., 1992b; Miller and Nusse, 1993) , and to cause cell cycle perturbations in vitro (Weller et al., 1995) . The lack of effect in vivo may be due to the inability of the compound to reach the bone marrow, or to acute toxic effects (Frankenberg and Sorbo, 1973; Ballantyne and Swanston, 1978) that limit the dosing to levels that do not induce MN. The PCE frequency in peripheral blood gives no indication of a cytotoxic effect of CS at any dose or sampling time. To our knowledge, no studies on the c-mitotic effects of CS in vivo have been made. Since it has been shown that the MN induced in vitro by CS consist mainly of single chromatids (Nusse et al., 1996) , the possible non-disjunction mechanism for aneuploidy induction described for CH is less likely for CS.
Flow cytometric enumeration of micronucleated erythrocytes has been used by several other groups (Hutter and Stohr, 1982; Hayashi et al, 1992a,b; Krishna et al., 1993; Tometsko et al., 1993a Tometsko et al., ,b, 1995 Cao et al., 1993) . The data presented here substantially increase the number of agents assessed for MN induction in mouse erythrocytes where flow cytometry based methods have been used. To date, data on 14 agents (in addition to the five agents tested in this report they are Xradiation, y-radiation, p-irradiation, cyclophosphamide, colchicine, vincristine, mitomycin C, acrylamide and butadiene) have been published with the method used herein (Grawe" et al., 1992 (Grawe" et al., , 1993a Zetterberg and Grawe", 1993; Cao et al., 1993; Adler et al., 1994; Abramsson-Zetterberg et al., 1995) . To our knowledge this is the largest number of agents tested with any of the published automated methods for micronucleus enumeration in erythrocytes.
In the case of clastogenic and aneugenic model compounds which are earlier characterised in terms of in vivo MN induction, the flow-based method gives results well in agreement with published data, both in terms of the frequency of induced MPCE as well as in terms of the indications for clastogenic or aneugenic mechanisms of action. We point out that even for HQ, with a complex mechanism for MN induction (Chen et al., 1994) an inspection of the dot plot is informative. Furthermore, for populations of flow sorted micronucleated bone marrow erythrocytes induced by the same agents as in this report the mean relative DNA content can be correlated to the proportion of these that are positive for centromere presence (Grawe et al, 1996) . For several of the agents, elevated frequencies of MPCE are detected at low dose levels in comparison with data from microscopic enumeration of MN, increasing the reliability of dose-response determinations in the low-dose region. The sensitivity of the method would allow the study of the possible in vivo threshold levels for MN induction. This requires quantitative information on the proportion of an agent reaching the bone marrow over a range of doses.
The capacity of the method to analyse large numbers of samples from peripheral blood makes it possible to study the kinetics of MPCE induction using few animals. The data in Table I were generated from only 48 animals.
In conclusion, flow cytometric enumeration of micronucleated polychromatic erythrocytes in the peripheral blood is an efficient tool for the study of chromosomal damage manifested as micronuclei of clastogenic or aneugenic origin.
